Bliss Gvs Pharma LimitedNSE: BLISSGVS

BLISSGVS: Q3 FY26 net profit reached ₹2,477.91 lakh; interim dividend of 0.50 paisa per share declared

· Issued by Bliss Gvs Pharma Limited

Unaudited results for Q3 FY26 show consolidated revenue of ₹21,825.19 lakh and net profit of ₹2,477.91 lakh. An interim dividend of 0.50 paisa per share was declared, and significant corporate actions included a subsidiary sale and new incorporations.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Bliss Gvs Pharma

All Bliss Gvs Pharma news releases